By Ankur Banerjee and Michael Erman The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said…
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – the final stage of testing before…
India will soon have administered 1 billion Covid-19 vaccine doses, but the milestone masks a yawning gap between the number of people who have been fully inoculated and those that…
AstraZeneca India Private Limited announced the launch of a clinical data and insights division in the country to further strengthen its global presence and manage data-related aspects of its clinical…
WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca…
United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from India’s Bharat Biotech regarding its COVID-19 jab Covaxin, asserting that it “cannot cut corners” before…
MUMBAI: Stockouts are being reported across the country of a key patented drug, Delaminid, used in drug-resistant tuberculosis (DR-TB), hampering the government’s goal of TB elimination and causing hardship to…
A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as…
By Nancy Lapid The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to…
London: People who had received a first dose of the Oxford-AstraZeneca Covid-19 vaccine and received an mRNA shot for their second dose had a lower risk of infection compared to…
